Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chronic Myelomonocytic Leukemia in Remission

Known as: CMML in Remission, Chronic Myelomonocytic Leukaemia (in Remission) 
Chronic myelomonocytic leukemia not growing; responding to treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
  • P. Valent
  • Best practice & research. Clinical haematology
  • 2020
  • Corpus ID: 213368417
Chronic myelomonocytic leukemia (CMML) is defined by myelodysplasia, pathologic accumulation of monocytes and a substantial risk… Expand
2018
2018
Background Molecular genetic abnormalities are observed in over 90% of chronic myelomonocytic leukemia (CMML) cases. Recently… Expand
  • table 1
  • table 3
  • table 2
  • figure 1
  • table 4
2018
2018
Bone marrow stromal cells (BMSCs) represent an important cellular component of the bone marrow microenvironment, which play an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
To the Editor, We thank the author for her comment and appreciate her concerns on the need for uniformity with regards to the… Expand
Review
2016
Review
2016
Itonaga et al. extensively evaluated the impact of Graft Versus ost Disease (GVHD) on the outcome of a large cohort of 141… Expand
2013
2013
We sought to describe the clinical features and outcomes of therapy-related chronic myelomonocytic leukemia (t-CMML) and compare… Expand
  • table 1
1998
1998
BACKGROUND The use of chemotherapy in juvenile chronic myelomonocytic leukemia (J-CMML) has not generally been successful. Our… Expand